Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Post

Showing results (301-310 of 319) with videos related to

Pageof 32
Sort By:
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Journal of Animal Science|June 10, 2024
Effect of bone and analytical method on assessment of bone mineralization in response to dietary phosphorus, phytase, and vitamin D in finishing pigsHadley R Williams, Mike D Tokach, Jason C Woodworth, et al.
Gastroenterology|January 24, 2007
Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalitiesFlorian Rieder, Ling Cheng, Karen M Harnett, et al.
Plos One|July 14, 2010
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensisMichael A Apicella, Deborah M B Post, Andrew C Fowler, et al.
Nature Cell Biology|April 2, 2021
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signallingBas Ponsioen, Jasmin B Post, Julian R Buissant des Amorie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationMerve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Gynecologic Oncology|March 13, 2021
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision makingCathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Plos One|February 9, 2026
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)A M de Jong, A T J van der Boog, C C B Post, et al.
Pageof 32

Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Gynecologic Oncology|March 15, 2022
Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)C C B Post, A M Westermann, I A Boere, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Journal of Animal Science|June 10, 2024
Effect of bone and analytical method on assessment of bone mineralization in response to dietary phosphorus, phytase, and vitamin D in finishing pigsHadley R Williams, Mike D Tokach, Jason C Woodworth, et al.
Gastroenterology|January 24, 2007
Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalitiesFlorian Rieder, Ling Cheng, Karen M Harnett, et al.
Plos One|July 14, 2010
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensisMichael A Apicella, Deborah M B Post, Andrew C Fowler, et al.
Nature Cell Biology|April 2, 2021
Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signallingBas Ponsioen, Jasmin B Post, Julian R Buissant des Amorie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 8, 2024
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter HypermethylationMerve Kaya, Cathalijne C B Post, Carli M Tops, et al.
Gynecologic Oncology|March 13, 2021
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision makingCathalijne C B Post, Jan Willem M Mens, Marie A D Haverkort, et al.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.
Plos One|February 9, 2026
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)A M de Jong, A T J van der Boog, C C B Post, et al.
Pageof 32